Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an intramuscular injection for intramuscular use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, acute pain and musculoskeletal disorders in adult patients.

GNH USA supplies Movalis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable logistics for global distribution, including temperature‑controlled shipping where required throughout.

Meloxicam is used to manage inflammatory and painful conditions affecting the musculoskeletal system.

- Osteoarthritis: reduces joint pain and improves mobility in patients with degenerative joint disease. - Rheumatoid arthritis: alleviates inflammation and pain, helping to preserve joint function in autoimmune arthritis. - Acute musculoskeletal pain: provides rapid relief of pain and swelling following injury or surgery. - Post‑operative pain: controls postoperative inflammation and discomfort after surgical procedures.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Injection site reactions: erythema, swelling or tenderness.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment: increased serum creatinine or reduced urine output. - Cardiovascular events: hypertension, edema or increased risk of thrombotic events.

When prescribing Meloxicam, clinicians should consider several precautionary measures to minimize risk.

- Renal function: assess baseline kidney function and monitor during therapy. - Cardiovascular risk: avoid in patients with uncontrolled hypertension or recent myocardial infarction. - Gastrointestinal history: use with caution in individuals with a history of ulcers or bleeding. - Concomitant anticoagulants: monitor for enhanced bleeding risk. - Pregnancy and lactation: avoid unless benefits outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - High‑dose aspirin or other NSAIDs: additive gastrointestinal toxicity. - ACE inhibitors or ARBs: may reduce renal function when combined.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced antihypertensive effect. - Lithium: may increase serum lithium levels. - Methotrexate: possible increased toxicity at high doses.